The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis.

Halma, Jennifer Christine; Cristoferi, Laura; Carbone, Marco

Halma, Jennifer Christine; Cristoferi, Laura; Carbone, Marco.

Affiliation

Halma JC; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Stanford University School of Medicine, Lucile Packard Children's Hospital, Stanford, California.
Cristoferi L; Division of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Carbone M; Division of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Clin Gastroenterol Hepatol ; 21(10): 2699-2700, 2023 09.

Article in En | MEDLINE | ID: mdl-36442726

Subject(s)

Cholangitis, Sclerosing; Colitis, Ulcerative; Humans; Vancomycin/therapeutic use; Cholangitis, Sclerosing/complications; Cholangitis, Sclerosing/drug therapy; Anti-Bacterial Agents/therapeutic use; Colitis, Ulcerative/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholangitis, Sclerosing / Colitis, Ulcerative Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google